Keyphrases
Blood Pressure
84%
Hypertension
66%
Placebo
62%
Essential Hypertension
54%
Arterial Elasticity
54%
Heart Failure
49%
Hypertensive Patients
46%
Arterial Compliance
43%
Cardiovascular Risk
41%
Hypertension Management
41%
Large Arteries
40%
Systolic Blood Pressure
38%
Atrial Fibrillation
37%
Insulin
37%
Antihypertensive Drugs
37%
Israel
36%
Aspirin
35%
Cytosolic Calcium
34%
Diastolic Blood Pressure
34%
Hazard Ratio
33%
Mean Arterial Pressure
32%
Confidence Interval
32%
Hemodynamic Effects
32%
Type 2 Diabetes Mellitus (T2DM)
32%
Systemic Vascular Resistance
31%
Spontaneously Hypertensive Rats
31%
Cardiovascular Mortality
30%
Cardiovascular Disease
29%
Cardiovascular Events
29%
Rivaroxaban
27%
Elasticity Index
26%
Small Artery Elasticity
26%
Coronary Artery Disease
26%
Hyperinsulinemia
25%
Artery Elasticity
25%
Small Arteries
25%
Diabetes
25%
Moderate to Severe
25%
Angiotensin II (Ang II)
24%
Dysglycemia
24%
Endothelin-1 (ET-1)
24%
Metabolic Parameters
24%
Heart Rate
24%
Randomized Placebo-controlled Trial
24%
Cardiac Output
23%
Cardiovascular Outcomes
23%
Laser Doppler Flowmetry
23%
Simvastatin
23%
Type 2 Diabetic Patients
23%
Cilazapril
23%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Antihypertensive Agent
68%
Congestive Heart Failure
50%
Cerebrovascular Accident
48%
Noradrenalin
46%
Essential Hypertension
43%
Non Insulin Dependent Diabetes Mellitus
42%
Acetylsalicylic Acid
41%
Calcium Ion
38%
Catecholamine
37%
Cardiovascular Disease
37%
Atrial Fibrillation
35%
Cardiovascular Risk
29%
Rivaroxaban
27%
Angiotensin Receptor Antagonist
25%
Heart Infarction
24%
Angiotensin II
24%
Dysglycemia
24%
Dipeptidyl Carboxypeptidase Inhibitor
24%
Coronary Artery Disease
24%
Spontaneously Hypertensive Rat
23%
Simvastatin
23%
Cilazapril
23%
Deoxyglucose
19%
Insulin Glargine
19%
Calcium Channel Blocker
17%
Losartan
17%
Metabolic Syndrome X
17%
Endothelin
17%
Isoprenaline
16%
Peripheral Occlusive Artery Disease
16%
Omega-3 Fatty Acid
16%
Tumor Necrosis Factor
16%
Vascular Disease
16%
Ischemic Heart Disease
16%
Low Density Lipoprotein Cholesterol
15%
Hyperinsulinemia
15%
Hyperlipidemia
15%
Rosiglitazone
15%
Candesartan
15%
Atorvastatin
15%
Beta Adrenergic Receptor Blocking Agent
15%
Acute Coronary Syndrome
15%
Ketanserin
15%
Dronedarone
15%
Bleeding
14%
Phosphatidylinositide
14%
Side Effect
14%
Angiotensin
13%
Amlodipine
12%
Medicine and Dentistry
Blood Pressure
71%
Cardiovascular System
37%
Maturity Onset Diabetes of the Young
36%
Placebo
36%
Artery Compliance
34%
Hemodynamic
34%
Congestive Heart Failure
28%
Mean Arterial Pressure
27%
Systolic Blood Pressure
26%
Diastolic Blood Pressure
26%
Diabetes
23%
Cardiovascular Disease
22%
Systemic Vascular Resistance
22%
Cardiovascular Risk
22%
Pulse Wave Velocity
21%
Calcium Ion
21%
Deoxyglucose
19%
Cardiology
19%
Essential Hypertension
19%
Hyperinsulinemia
18%
Peripheral Vascular Disease
17%
Dysglycemia
16%
Insulin Glargine
16%
Tumor Necrosis Factor
16%
Acetylsalicylic Acid
16%
Isotopes of Calcium
15%
Patient with Type 2 Diabetes
15%
Rosiglitazone
15%
Arterial Stiffness
15%
Breathing
15%
Laser Doppler Flowmetry
15%
Calcium Channel Blocking Agent
15%
Low-Density Lipoprotein
15%
Phosphatidylinositide
14%
Capillary Flow
13%
Atrial Fibrillation
13%
Mortality Rate
13%
Cardiac Muscle Cell
13%
Receptor
12%
Rivaroxaban
12%
Body Mass Index
12%
Hazard Ratio
12%
Adenosine
11%
Secretagogue
11%
Thyroid Hormone
11%
Apoplexy
11%
Opioid Receptor
11%
Arm
10%
Odds Ratio
10%
Hypercholesterolemia
10%